Solid Tumors: Gynecology, Prostate & GI Malignancies
By: Thomas Herzog, MD; Ulka Vaishampayan, MD; Ahmed Zakari, MD
Predictive and Prognostic: Value of TMB, MSI and PD-L1 in Liquid and Solid Tumor Specimens.
By: Ticiana A. Leal, MD
How to Monitor and Management Complications from Direct Thrombin Inhibitors
By: ADALBERTO TORRES-HERNÁNDEZ
Integrative Oncology: Treatment Approaches for Stress in Cancer Patients and Survivors
By: Ashwin Mehta, MD, MPH
Integrative Oncology: Treatment Approaches for Stress in Cancer Patients and Survivors
By: Ashwin Mehta, MD, MPH
Integrative Oncology: Treatment Approaches for Stress in Cancer Patients and Survivors
By: Ashwin Mehta, MD, MPH
Integrative Oncology: Treatment Approaches for Stress in Cancer Patients and Survivors
By: Ashwin Mehta, MD, MPH
Managing Symptoms & Supportive Care
By: Jorge J. García, PharmD, MS, MHA, MBA, FACHE; Rosanna Rodriguez, PA-C; Mildred Flores, RN, PhD
Most Common Adverse Events of Checkpoint Inhibitors | Current Recommendations and Management
By: Meri Tarockoff, MD
Most Common Adverse Events of Checkpoint Inhibitors | Current Recommendations and Management
By: Meri Tarockoff, MD
Toxicity Profiles, Supportive Care and Challenges in Cancer Therapy Session
By: Nicole Ianniello, PharmD, Alga S. Ramos Morales, PharmD, MS, BCPS, BCOP, Ashwin Mehta, MD, MPH, Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE, Jorge Adames, PA, RN, BSN, OCN®, CCRP
